The family of sensorimotor gating disorders: Comorbidities or diagnostic overlaps?
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Prepulse inhibition (PPI) of startle is an operational measure of the pre-attentive filtering process known as sensorimotor gating. Originally identified in patients with schizophrenia, PPI deficits have been observed in multiple but not all psychiatric disorders. Thus, as with most signs and symptoms of psychiatric disorders, deficits in PPI cut across diagnostic categories. It remains unclear whether the diversity of disorders exhibiting deficient PPI bespeaks diagnostic overlaps or comorbidities. Given the recent focus on treatments for cognitive deficits of schizophrenia independently of treating psychosis, the relationship of PPI deficits to cognitive deficits becomes of interest. Although PPI cannot be considered to be a cognitive process per se, abnormalities in pre-attentive information processing may be predictive of or lead to complex cognitive deficits. Animal models of PPI deficits produced by dopamine agonists reliably predict existing antipsychotics. Nevertheless, since neither PPI nor cognitive deficits in schizophrenia are ameliorated by standard antipsychotics, current research is exploring the predictive value of non-dopaminergic PPI models in identifying treatments for gating disturbances independently of their relevance to specific disorders. Both PPI and cognitive deficits in schizophrenia patients are not reversed by first generation antipsychotics but may be attenuated by clozapine. Similarly, effects of glutamate antagonists on symptoms in patients and PPI in animals appear to be reduced by clozapine. Hence, treatment-induced reversals of deficits in PPI produced by glutamate antagonists may provide animal, and human, models to aid in the discovery of treatments of cognitive deficits in patients already treated with existing antipsychotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pallidal, thalamic, and motor cortex activity is also associated with checking symptoms in OCD(89).”
From Functional disruption of cerebello-thalamo-cortical networks in obsessive-compulsive disorder (2020) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Self-citationGeyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Self-citationLongitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
Green, M. F., Kern, R. S., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.009 · Cited by 1,422 · cited 2×
“Third, a consensus process was used to develop recommendations for the appropriate cognitive tests to be used in clinical assessments of potential cognitive enhancers (Green et al., 2004b).”
BackgroundMethodSensorimotor Gating and Schizophrenia: Human and Animal Model Studies
Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,309
Self-citationIdentification of separable cognitive factors in schizophrenia
Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304 · cited 1×
“ucla.edu). First, the Neurocognition Committee identified the primary domains of cognitive deficits that characterize patients with schizophrenia: working memory; attention/vigilance; verbal learning and memory; visual learning and memory; speed of processing; reasoning and problem-solving; and social cognition ( Nuec…”
BackgroundPrestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,170
Self-citationThe more or less startling effects of weak prestimulation
Graham, F. K. (1975) · Psychophysiology · doi:10.1111/j.1469-8986.1975.tb01284.x · Cited by 1,119
Swerdlow, N., Geyer, M., & Braff, D. (2001) · Psychopharmacology · doi:10.1007/s002130100799 · Cited by 1,050
Self-citation
Research works printed but not linked: 1
- Geyer MA and A Markou (2002) The role of preclinical models in the development of psychotropic drugs, In:Neuropsychopharm-acology: The Fifth Generation of Progress (Davis KL, D Charney, J.T. Coyle and C Nemeroff, Eds.) (Lippincott Williams and Wilkins:Philadelphia, PA), pp 445–455.
Cited by
Schizophrenia, “Just the Facts”: What we know in 2008
Tandon, R., Keshavan, M. S., & Nasrallah, H. A. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.01.022 · Cited by 409
Ramonet, D., Daher, J. P. L., Lin, B. M., Stafa, K., Kim, J., Banerjee, R., Westerlund, M., Pletnikova, O., Glauser, L., Yang, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018568 · Cited by 405
“We also assessed prepulse inhibition of the acoustic startle reflex, a measure of sensorimotor gating that can be modulated in part by dopaminergic neurotransmission [39].”
MethodEpidemiology-driven neurodevelopmental animal models of schizophrenia
Meyer, U., & Feldon, J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 372
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
KESHAVAN, M., TANDON, R., BOUTROS, N., & NASRALLAH, H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.020 · Cited by 347
Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models
Markou, A., Chiamulera, C., Geyer, M. A., Tricklebank, M., & Steckler, T. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.173 · Cited by 328
“…Cryan et al, 2002; Millan and Brocco, 2003; Matthews and Robbins, 2003; Willner, 2005; Einat and Manji, 2006; Steckler et al, 2008; Gotz et al, 2004; Janus et al, 2007; Geyer 2006a; Ellenbroek and Cools, 2000; Carter et al, 2008; Enomoto et al, 2007; McGowan et al, 2006; Gotz and Ittner, 2008).”
InfluentialSelf-citationPhysical Exercise Protects Against Alzheimer's Disease in 3xTg-AD Mice
García-Mesa, Y., López-Ramos, J. C., Giménez-Llort, L., Revilla, S., Guerra, R., Gruart, A., LaFerla, F. M., Cristòfol, R., Delgado-García, J. M., & Sanfeliu, C. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101635 · Cited by 253
Autistic Disorders and Schizophrenia: Related or Remote? An Anatomical Likelihood Estimation
Cheung, C., Yu, K., Fung, G., Leung, M., Wong, C., Li, Q., Sham, P., Chua, S., & McAlonan, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012233 · Cited by 180
Autism-Relevant Social Abnormalities and Cognitive Deficits in Engrailed-2 Knockout Mice
Brielmaier, J., Matteson, P. G., Silverman, J. L., Senerth, J. M., Kelly, S., Genestine, M., Millonig, J. H., DiCicco-Bloom, E., & Crawley, J. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040914 · Cited by 157
Predictive animal models of mania: hits, misses and future directions
Young, J. W., Henry, B. L., & Geyer, M. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01318.x · Cited by 132
Self-citationHiroi, N., Takahashi, T., Hishimoto, A., Izumi, T., Boku, S., & Hiramoto, T. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.92 · Cited by 124
The Role of Dopamine D3 Receptors in Antipsychotic Activity and Cognitive Functions
Groß, G., & Drescher, K. U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_7 · Cited by 117
Crabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 101
Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms From CNTRICS
Green, M. F., Butler, P. D., Chen, Y., Geyer, M. A., Silverstein, S., Wynn, J. K., Yoon, J. H., & Zemon, V. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn156 · Cited by 113
Self-citationAnimal Models of Schizophrenia
Young, J. W., Zhou, X., & Geyer, M. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_62 · Cited by 107
Self-citationGene models of schizophrenia: DISC1 mouse models
Jaaro-Peled, H. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17909-8 · Cited by 101
Alterations of dopamine and serotonin transmission in schizophrenia
Remington, G. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00906-0 · Cited by 95
Vorhees, C. V., Graham, D. L., Braun, A. A., Schaefer, T. L., Skelton, M. R., Richtand, N. M., & Williams, M. T. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.10.007 · Cited by 72
Does tinnitus "fill in" the silent gaps?
Salvi, R., Campolo, J., & Lobariñas, E. (2013) · Noise and Health · doi:10.4103/1463-1741.121232 · Cited by 92
Knockout of GAD65 has Major Impact on Synaptic GABA Synthesized from Astrocyte-Derived Glutamine
Walls, A. B., Eyjolfsson, E. M., Smeland, O. B., Nilsen, L. H., Schousboe, I., Schousboe, A., Sonnewald, U., & Waagepetersen, H. S. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.115 · Cited by 77
Young, J. W., Powell, S. B., Scott, C. N., Zhou, X., & Geyer, M. A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.054 · Cited by 80
Self-citationCampbell, L., Hughes, M. E., Budd, T. W., Cooper, G. J., Fulham, W. R., Karayanidis, F., Hanlon, M., Stojanov, W., Johnston, P., Case, V., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05858.x · Cited by 83
Test, rinse, repeat: A review of carryover effects in rodent behavioral assays
Cnops, V., Iyer, V. R., Parathy, N., Wong, P., & Dawe, G. S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104560 · Cited by 81
Prepulse Inhibition of Startle Response: Recent Advances in Human Studies of Psychiatric Disease
Takahashi, H., Hashimoto, R., Iwase, M., Ishii, R., Kamio, Y., & Takeda, M. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.3.102 · Cited by 81
Errico, F., Mothet, J., & Usiello, A. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.03.024 · Cited by 75
Pharmacological animal models of Tourette syndrome
Bronfeld, M., Israelashvili, M., & Bar‐Gad, I. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.010 · Cited by 73
Savonenko, A., Munoz, P., Melnikova, T., Wang, Q., Liang, X., Breyer, R. M., Montine, T. J., Kirkwood, A., & Andreasson, K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.016 · Cited by 66
Roussos, P., Giakoumaki, S. G., & Bitsios, P. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.003 · Cited by 66
Behavioral and molecular evidence for psychotropic effects in l-theanine
Wakabayashi, C., Numakawa, T., Ninomiya, M., Chiba, S., & Kunugi, H. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2440-z · Cited by 65
“, AP-5, phencyclidine, MK-801 [dizocilpine], and ketamine) produce robust deficits in PPI in rodents (Geyer 2006; Geyer et al. 2001; Kretschmer and Koch 1997; Mansbach and Geyer 1989).”
BackgroundKumari, V., Gudjonsson, G. H., Raghuvanshi, S., Barkataki, I., Taylor, P., Sumich, A., Das, K., Kuipers, E., Ffytche, D. H., & Das, M. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.03.002 · Cited by 55
Asp, L., Holtze, M., Powell, S. B., Karlsson, H., & Erhardt, S. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990253 · Cited by 53
Boku, S., Toda, H., Nakagawa, S., Kato, A., Inoue, T., Koyama, T., Hiroi, N., & Kusumi, I. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.07.008 · Cited by 56
Effect of a multinutrient intervention after ischemic stroke in female C57Bl/6 mice
Wiesmann, M., Timmer, N., Zinnhardt, B., Reinhard, D., Eligehausen, S., Königs, A., Jeddi, H. B., Dederen, P. J. W. C., Jacobs, A. H., & Kiliaan, A. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14213 · Cited by 56
Singer, P., Hauser, J., López, L., Peleg‐Raibstein, D., Feldon, J., Gargiulo, P. Á., & Yee, B. K. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.011 · Cited by 55
Blundell, J., Kaeser, P. S., Südhof, T. C., & Powell, C. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0328-10.2010 · Cited by 44
Singer, P., Feldon, J., & Yee, B. K. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1568-6 · Cited by 51
Bator, E., Latusz, J., Wędzony, K., & Maćkowiak, M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.11.013 · Cited by 49
Functional disruption of cerebello-thalamo-cortical networks in obsessive-compulsive disorder
Sha, Z., Edmiston, E. K., Versace, A., Fournier, J. C., Graur, S., Greenberg, T., Lima Santos, J. P., Chase, H. W., Stiffler, R. S., Bonar, L., et al. (2020) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.002 · Cited by 48
“Altered connectivity in these regions might underlie sensorimotor gating anomalies in OCD described in prepulse inhibition studies(88).”
BackgroundChen, H.-H., Stoker, A., & Markou, A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1802-2 · Cited by 44
MacLaren, D. A. A., Markovic, T., & Clark, S. D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12716 · Cited by 48
Neurodegeneration in schizophrenia
Archer, T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.152 · Cited by 47
Hiroi, N. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12641 · Cited by 44
Feinstein, I., & Kritzer, M. F. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.026 · Cited by 43
Aguilar‐Valles, A., & Luheshi, G. N. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.006 · Cited by 42
Behavioral Animal Models of Antipsychotic Drug Actions
Peleg‐Raibstein, D., Feldon, J., & Meyer, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_14 · Cited by 41
Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders
Palomo, T., Kostrzewa, R. M., Beninger, R. J., & Archer, T. (2007) · Neurotoxicity Research · doi:10.1007/bf03033900 · Cited by 40
Fitsanakis, V. A., Thompson, K. N., Deery, S. E., Milatović, D., Shihabi, Z. K., Erikson, K. M., Brown, R. W., & Aschner, M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9017-1 · Cited by 40
Comings, D. E., Chen, T. J., Blum, K., Mengucci, J. F., Blum, S. H., & Meshkin, B. (2005) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-2-50 · Cited by 32
Gururajan, A., Hill, R., & van den Buuse, M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.009 · Cited by 39
The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?
Peleg‐Raibstein, D., Yee, B. K., Feldon, J., & Hauser, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1514-7 · Cited by 39
Roussos, P., Giakoumaki, S. G., Adamaki, E., Georgakopoulos, A., Nikos, R. K., & Bitsios, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.49 · Cited by 38
Estrogen abolishes latent inhibition in ovariectomized female rats
Nofrey, B. S., Ben‐Shahar, O., & Brake, W. G. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2007.06.003 · Cited by 38
Nose-Ishibashi, K., Watahiki, J., Yamada, K., Maekawa, M., Watanabe, A., Yamamoto, G., Enomoto, A., Matsuba, Y., Nampo, T., Taguchi, T., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2013.12.065 · Cited by 36
Santos‐Carrasco, D., & la Casa, L. G. D. (2023) · BMC Psychology · doi:10.1186/s40359-023-01253-9 · Cited by 36
Hiroi, N., & Yamauchi, T. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz026 · Cited by 23
Cannon, C. E., Puri, V., Vivian, J. A., Egbertson, M. S., Eddins, D. M., & Uslaner, J. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.003 · Cited by 34
Eddins, D. M., Hamill, T. G., Puri, V., Cannon, C. E., Vivian, J. A., Bohorquez, S. M. S., Cook, J. J., Morrow, J. A., THOMSON, F. J., & Uslaner, J. M. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3260-0 · Cited by 34
Sensorimotor gating and clinical outcome following cognitive behaviour therapy for psychosis
Kumari, V., Premkumar, P., Fannon, D. G., Aasen, I., Raghuvanshi, S., Anilkumar, A. P., Antonova, E., PETERS, E. R., & Kuipers, E. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.11.020 · Cited by 33
Yee, B. K., & Feldon, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.049 · Cited by 33
Ulivieri, M., Wierońska, J. M., Lionetto, L., Martinello, K., Cieślik, P., Chocyk, A., Curto, M., Menna, L. D., Iacovelli, L., Traficante, A., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa074 · Cited by 32
Epigenetics and Biomarkers in the Staging of Neuropsychiatric Disorders
Archer, T., Beninger, R. J., Palomo, T., & Kostrzewa, R. M. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9163-5 · Cited by 31
Bowers, W. J., Wall, P. M., Nakai, J. S., Yagminas, A. P., Wade, M. G., & Li, N. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.08.002 · Cited by 31
Frau, R., Traccis, F., & Bortolato, M. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12792 · Cited by 31
Differences in startle reflex and prepulse inhibition in European‐Americans and African‐Americans
Hasenkamp, W. M., Norrholm, S. D., Green, A. M., Lewison, B., Boshoven, W., Keyes, M. D., & Duncan, E. (2008) · Psychophysiology · doi:10.1111/j.1469-8986.2008.00680.x · Cited by 31
Deslauriers, J., Racine, W., Sarret, P., & Grignon, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.04.061 · Cited by 30
Toll-like receptor 9 deficiency impacts sensory and motor behaviors
Khariv, V., Pang, K. C. H., Servatius, R. J., David, B. T., Goodus, M. T., Beck, K. D., Heary, R. F., & Elkabes, S. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.04.007 · Cited by 29
Mouse Models of 22q11.2-Associated Autism Spectrum Disorder
Hiroi, N., Hiramoto, T., Harper, K. M., Suzuki, G., & Boku, S. (2012) · Autism - Open Access · doi:10.4172/2165-7890.s1-001 · Cited by 28
Morello, F., Võikar, V., Parkkinen, P., Panhelainen, A. E., Rosenholm, M., Makkonen, A., Rantamäki, T., Piepponen, P. T., Aitta‐aho, T., & Partanen, J. M. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01033-8 · Cited by 29
Ettinger, U., & Kumari, V. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00313-2 · Cited by 27
Tejeda, H. A., Chefer, V. I., Zapata, A. G., & Shippenberg, T. S. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1799-6 · Cited by 27
Beyaert, M. G. R., Daya, R. P., Dyck, B. A., Johnson, R. L., & Mishra, R. K. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.010 · Cited by 27
Cadeddu, R., Knutson, D. E., Mosher, L. J., Loizou, S., Odeh, K., Fisher, J. L., Cook, J. M., & Bortolato, M. (2021) · Biomolecules · doi:10.3390/biom11020175 · Cited by 25
Gururajan, A., TAYLOR, D. A. H. B., & Malone, D. T. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.11.005 · Cited by 25
Cholinergic Neurons of the Medial Septum Are Crucial for Sensorimotor Gating
Jin, J., Cheng, J., Lee, K.-W., Amreen, B., McCabe, K. A., Pitcher, C., Liebmann, T., Greengard, P., & Flajolet, M. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0950-18.2019 · Cited by 24
Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia
Tizabi, Y. (2007) · Neurotoxicity Research · doi:10.1007/bf03033907 · Cited by 24
Abnormal neuronal activity in Tourette syndrome and its modulation using deep brain stimulation
Israelashvili, M., Loewenstern, Y., & Bar‐Gad, I. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00277.2015 · Cited by 23
Bator, E., Latusz, J., Głowacka, U., Radaszkiewicz, A., Mudlaff, K., & Maćkowiak, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9888-0 · Cited by 22
Pereira-Figueiredo, I., Castellano, O., Riolobos, A. S., Ferreira-Dias, G. M., López, D. E., & Sancho, C. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00099 · Cited by 21
Hasenkamp, W. M., Kelley, M. E., Egan, G. J., Green, A. M., Wilcox, L., Boshoven, W., Lewison, B., & Duncan, E. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.02.011 · Cited by 21
Cao, T., Tang, M., Jiang, P., Zhang, B., Wu, X., Chen, Q., Zeng, C., Li, N., Zhang, S., & Cai, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.612083 · Cited by 20
Jaaro-Peled, H., Kumar, S., Hughes, D. N., Sumitomo, A., Kim, S.-H., Zoubovsky, S. P., Hirota-Tsuyada, Y., Zala, D., Bruyère, J., Katz, B. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01389-3 · Cited by 19
Mosher, L. J., Cadeddu, R., Yen, S., Staudinger, J. L., Traccis, F., Fowler, S. C., Maguire, J. L., & Bortolato, M. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.06.009 · Cited by 19
Ünal, G., Ates, A. M., & Arıcıoğlu, F. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1426696 · Cited by 18
Dubroqua, S., Low, S. R. L., Yee, B. K., & Singer, P. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3703-2 · Cited by 18
Kponee, K. Z., Weisskopf, M. G., Grashow, R. G., Rotem, R. S., Coull, B. A., Schnaas, L., Hernández-Chávez, M. D. C., Sánchez, B. N., Peterson, K. E., Hu, H., et al. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.02.013 · Cited by 18
Vorhees, C. V., Morford, L. L., Graham, D. L., Skelton, M. R., & Williams, M. T. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-41 · Cited by 18
Dimensional Deconstruction and Reconstruction of CNV-Associated Neuropsychiatric Disorders
Hiroi, N., & Nishi, A. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00017-1 · Cited by 18
Sex Differences in Psychosis: Focus on Animal Models
Gogos, A., & van den Buuse, M. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_305 · Cited by 17
Cès, A., Reiss, D. J., Walter, O., Wichmann, J., Prinssen, E. P. M., Kieffer, B. L., & Ouagazzal, A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.175 · Cited by 17
Meirsman, A. C., d’Exaerde, A. D. K., Kieffer, B. L., & Ouagazzal, A. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13646 · Cited by 16
Nespor, A. A., & Tizabi, Y. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1220-x · Cited by 16
Jenkins, B. W., Moore, C. F., Jantzie, L. L., & Weerts, E. M. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106207 · Cited by 15
Bilecki, W., Wawrzczak‐Bargieła, A., Majcher‐Maślanka, I., Chmelová, M., & Maćkowiak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168710 · Cited by 15
Bratzu, J., Ciscato, M., Pisanu, A., Talani, G., Frau, R., Porcu, P., Diana, M., Fumagalli, F., Romualdi, P., Rullo, L., et al. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1257417 · Cited by 15
Defizite der sensomotorischen Filterleistung bei psychiatrischen Erkrankungen
Quednow, B. B. (2008) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x.19.3.139 · Cited by 15
Role of the NMDA-receptor in Prepulse Inhibition in the Rat
Linderholm, K. R., Powell, S. B., Olsson, E., Holtze, M., Snodgrass, R., & Erhardt, S. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4260 · Cited by 15
Electrophysiology of Visual and Auditory Perception in Autism Spectrum Disorders
Yamasaki, T., Maekawa, T., Takahashi, H., Fujita, T., Kamio, Y., & Tobimatsu, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_39 · Cited by 15
Stressing out! Effects of acute stress on prepulse inhibition and working memory
Santos‐Carrasco, D., & la Casa, L. G. D. (2024) · Psychophysiology · doi:10.1111/psyp.14599 · Cited by 14
Peleg‐Raibstein, D., Singer, P., Feldon, J., & Yee, B. K. (2015) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-015-0356-5 · Cited by 14
Scheggi, S., Concas, L., Corsi, S., Carta, M., Melis, M., & Frau, R. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105842 · Cited by 13
Østerbøg, T. B., On, D. M., Oliveras, I., Río-Álamos, C., Sánchez-González, A., Tapias-Espinosa, C., Tobeña, A., González‐Maeso, J., Fernández‐Teruel, A., & Aznar, S. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01829-w · Cited by 13
Metadata
- Authors
- Geyer, M. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Geyer, Mark A.
- ORCID
- Geyer, Mark A.
- Venue
- Neurotoxicity Research
- Published
- 2006-09
- Volume
- 10
- Issue
- 3-4
- Pages
- 211-220
- ISSN
- 1029-8428 (ISSN-L)
- 1476-3524
- PMC
- PMC2667105
- OpenAlex
- W1988299084
- Cited by
- 159
- References
- 70
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 5 · 2020: 6 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 4 · 2015: 9 · 2014: 11 · 2013: 8 · 2012: 10
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurotoxicity Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH42228, R37MH042228, MH61326, R01MH071916, R01MH042228, R01MH061326, MH071916)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- prepulse inhibition, sensorimotor gating, schizophrenia, cognitive impairment, comorbidities, diagnostic overlap, clozapine, antipsychotic drugs, glutamate receptor antagonists, dopamine agonists, animal models
- MeSH terms
- Animals, Dopamine, Humans, Movement Disorders, Schizophrenia, Schizophrenic Psychology, Sensation Disorders, Reflex, Startle, Drug Design, Receptors, N-Methyl-D-Aspartate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.